NO924385L - Preparat for oral langtidsbehandling av astma - Google Patents

Preparat for oral langtidsbehandling av astma

Info

Publication number
NO924385L
NO924385L NO92924385A NO924385A NO924385L NO 924385 L NO924385 L NO 924385L NO 92924385 A NO92924385 A NO 92924385A NO 924385 A NO924385 A NO 924385A NO 924385 L NO924385 L NO 924385L
Authority
NO
Norway
Prior art keywords
astma
preparation
long treatment
oral long
oral
Prior art date
Application number
NO92924385A
Other languages
English (en)
Other versions
NO924385D0 (no
Inventor
Max Rombi
Original Assignee
Arkopharma Laboratoires
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arkopharma Laboratoires filed Critical Arkopharma Laboratoires
Publication of NO924385D0 publication Critical patent/NO924385D0/no
Publication of NO924385L publication Critical patent/NO924385L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO92924385A 1991-11-14 1992-11-13 Preparat for oral langtidsbehandling av astma NO924385L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9114008A FR2683722B1 (fr) 1991-11-14 1991-11-14 Medicament pour le traitement de fond de l'asthme a base de beta-carotene.

Publications (2)

Publication Number Publication Date
NO924385D0 NO924385D0 (no) 1992-11-13
NO924385L true NO924385L (no) 1993-05-18

Family

ID=9418900

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924385A NO924385L (no) 1991-11-14 1992-11-13 Preparat for oral langtidsbehandling av astma

Country Status (3)

Country Link
EP (1) EP0542632A1 (no)
FR (1) FR2683722B1 (no)
NO (1) NO924385L (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996023489A2 (de) * 1995-02-03 1996-08-08 Basf Aktiengesellschaft Verwendung von carotinoiden zur herstellung von arzneimitteln zur behandlung von dermatosen
GB2312621B (en) * 1996-05-02 1998-03-11 Pharma Nord Uk Limited Anti-oxidant medicament
US7723327B2 (en) 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
WO2005102356A1 (en) * 2004-04-14 2005-11-03 Hawaii Biotech, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
WO2008118862A1 (en) 2007-03-23 2008-10-02 Cardax Pharmaceuticals, Inc. Carotenoid analogs and derivatives for the prevention of platelet aggregation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975519A (en) * 1975-06-09 1976-08-17 University Of Virginia Method for increasing the oxygen partial pressure in the bloodstream of mammals
DE3542309A1 (de) * 1985-11-29 1987-06-04 Cardona Federico Dr Medizinisches antioxidativum
DE3722647A1 (de) * 1987-07-09 1989-01-19 Gerhard Ohlenschlaeger Galenische verwendung eines tripeptids als arzneimittel
US4927850A (en) * 1988-04-08 1990-05-22 Bayless Robert K Antioxidant compositions and methods for ameliorating inflammatory symptoms of respiratory disease

Also Published As

Publication number Publication date
EP0542632A1 (fr) 1993-05-19
FR2683722B1 (fr) 1995-05-24
FR2683722A1 (fr) 1993-05-21
NO924385D0 (no) 1992-11-13

Similar Documents

Publication Publication Date Title
NO174572C (no) Oralt preparat
NO179503C (no) Oralt preparat
NO934547D0 (no) Oral behandling av Helicobacter-in-feksjon
NO921958L (no) Farmasoeytisk preparat
NO922006L (no) Farmasoeytisk preparat
NO871790D0 (no) Fremgangsmaate for fremstilling av et oralt farmasoeytisk preparat.
NO924461D0 (no) Dipyridamol for behandling av proliferaktive sykdommer
DK0577306T3 (da) Præparat til oral hygiejne
NO179161C (no) Oralt preparat
NO953254D0 (no) Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter
NO923765L (no) Et trinns fremgangsmaate for fremstilling av dirithromycin
FI940775A0 (fi) alfa-fenyyli-isoseriinijohdannaisten valmistusmentelmä ja niiden käyttö
DE59205779D1 (de) Zahnärztliches handstück
FI902653A0 (fi) Valmiste hampaiden hoitamiseksi sekä valmisteen valmistus
NO920049D0 (no) Fremgangsmaate for fremstilling av 3-eksometylencefamsulfoksydestere
NO924385L (no) Preparat for oral langtidsbehandling av astma
DE69219146D1 (de) Oraler inhalator
KR930702990A (ko) 섬유성 질병 치료제로서의 프로스타사이클린- 및 카르바사이클린 유도체
FI97951B (fi) Menetelmä kiinteiden oraalisesti käytettävien ifosfamidivalmisteiden valmistamiseksi
NO170569C (no) Fremgangsmaate for fremstilling av preparat for oral dosering av etoposid
NO933262D0 (no) Fremgangsmaate for fremstilling av alkosymagnesiumhalogenider
NO923290L (no) Fremgangsmaate for fremstilling av metylacetat
ATA159391A (de) Zahnaerztliches handstueck
NO924763D0 (no) Ny fremgangsmaate for fremstilling av 4-amino-5-hexensyre
NO922709L (no) Fremgangsmaate for fremstilling av vanadium-bis-arener